Choosing an antihypertensive combination with a more efficient central blood pressure reduction
- PMID: 21090926
- DOI: 10.1586/erc.10.144
Choosing an antihypertensive combination with a more efficient central blood pressure reduction
Abstract
Not all blood pressure (BP)-lowering agents have the same effect on central BP, but we know that central BP, in itself, is a risk factor for cardiovascular diseases. Therefore, antihypertensive agents should ideally also have a central BP-lowering effect. In this paper the authors evaluate the effect of adding a calcium channel blocker to a β-blocker. The results show this combination does not reverse the lesser effect of β-blockers on central BP, and that the combination of valsartan plus amlodipine is more effective in lowering central BP than a combination of amlodipine plus atenolol.
Comment on
-
Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study.Hypertension. 2010 Jun;55(6):1314-22. doi: 10.1161/HYPERTENSIONAHA.109.148999. Epub 2010 Apr 19. Hypertension. 2010. PMID: 20404219 Clinical Trial.
Similar articles
-
Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.Am J Cardiovasc Drugs. 2009;9(5):309-30. doi: 10.2165/11201120-000000000-00000. Am J Cardiovasc Drugs. 2009. PMID: 19791840 Review.
-
Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.Clin Ther. 2007 Feb;29(2):279-89. doi: 10.1016/j.clinthera.2007.02.003. Clin Ther. 2007. PMID: 17472820 Clinical Trial.
-
Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.Chronobiol Int. 2010 Jul;27(6):1287-303. doi: 10.3109/07420528.2010.489167. Chronobiol Int. 2010. PMID: 20653455 Clinical Trial.
-
Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.Adv Ther. 2008 May;25(5):399-411. doi: 10.1007/s12325-008-0054-6. Adv Ther. 2008. PMID: 18465097 Clinical Trial.
-
Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.Adv Ther. 2008 Apr;25(4):300-20. doi: 10.1007/s12325-008-0042-x. Adv Ther. 2008. PMID: 18449492 Review.
Publication types
LinkOut - more resources
Full Text Sources